Research ArticleArticle
Identification of an EGFRvIII-JNK2-HGF/c-Met–Signaling Axis Required for Intercellular Crosstalk and Glioblastoma Multiforme Cell Invasion
Vanessa C. Saunders, Marie Lafitte, Isabel Adrados, Victor Quereda, Daniel Feurstein, YuanYuan Ling, Mohammad Fallahi, Laura H. Rosenberg and Derek R. Duckett
Molecular Pharmacology December 2015, 88 (6) 962-969; DOI: https://doi.org/10.1124/mol.115.097774
Vanessa C. Saunders
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Marie Lafitte
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Isabel Adrados
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Victor Quereda
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Daniel Feurstein
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
YuanYuan Ling
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Mohammad Fallahi
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Laura H. Rosenberg
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Derek R. Duckett
Department of Molecular Therapeutics (V.C.S., M.L., I.A., V.Q., D.F., Y.L., D.R.D.), Informatics Core, Scripps Research Institute, Jupiter, Florida (M.F.) and Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, United Kingdom (L.H.R.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
JNK2 Mediates EGFRvIII-Driven HGF Production
Vanessa C. Saunders, Marie Lafitte, Isabel Adrados, Victor Quereda, Daniel Feurstein, YuanYuan Ling, Mohammad Fallahi, Laura H. Rosenberg and Derek R. Duckett
Molecular Pharmacology December 1, 2015, 88 (6) 962-969; DOI: https://doi.org/10.1124/mol.115.097774
Research ArticleArticle
JNK2 Mediates EGFRvIII-Driven HGF Production
Vanessa C. Saunders, Marie Lafitte, Isabel Adrados, Victor Quereda, Daniel Feurstein, YuanYuan Ling, Mohammad Fallahi, Laura H. Rosenberg and Derek R. Duckett
Molecular Pharmacology December 1, 2015, 88 (6) 962-969; DOI: https://doi.org/10.1124/mol.115.097774
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement